Intelligent Void Filling Prosthetic Systems

A next-generation void filling prosthetic system that leverages AI, AR, and modular design to provide personalized, minimally invasive, and adaptive joint replacements.

The original patent for void filling joint prostheses and associated instruments has limitations in terms of customization, surgical complexity, and patient outcomes. The new inventive concept addresses these limitations by integrating advanced technologies to create a more efficient, effective, and patient-centric solution.

The system comprises a neural network trained to predict optimal void filling prosthesis geometries based on patient-specific anatomical data, generating customized prosthesis designs. The system also includes a real-time AR guidance module for precise spatial awareness during surgery, and a modular prosthesis with interchangeable components for adaptive customization. Additionally, a bioreactor system cultivates patient-derived stem cells on the prosthesis, promoting enhanced osseointegration and tissue regeneration. The robotic-assisted surgical platform enables minimally invasive implantation with real-time navigation and precision placement capabilities.

The new claims introduce a paradigm shift in void filling prosthetic systems by incorporating AI-driven design, AR guidance, modular customization, bioreactor-based tissue regeneration, and robotic-assisted surgery. These advancements provide a significant improvement over the original patent, offering a more personalized, efficient, and effective solution for joint replacement surgery.

Alternative embodiments may include variations in AI algorithms, AR visualization modalities, modular component designs, bioreactor systems, and robotic-assisted surgical platforms. These variations could be tailored to specific joints, patient populations, or surgical approaches, ensuring broad conceptual coverage.

The intelligent void filling prosthetic system has significant commercial potential in the orthopedic industry, with applications in joint replacement surgery, sports medicine, and regenerative medicine. The target market includes orthopedic surgeons, hospitals, and medical device manufacturers seeking to improve patient outcomes and reduce healthcare costs.